Cargando…
Biological response modifier glucan through balancing of blood glucose may have a prophylactic potential in COVID-19 patients
With the COVID-19 pandemic causing huge threat to public health and definite treatment modalities and preventive vaccines yet to be arrived at, some of the key indicators of relevance to its prognosis have started emerging. One such independent predictor of outcome has been fasting plasma glucose (F...
Autores principales: | Ikewaki, Nobunao, Iwasaki, Masaru, Abraham, Samuel J. K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575334/ https://www.ncbi.nlm.nih.gov/pubmed/33102263 http://dx.doi.org/10.1007/s40200-020-00664-4 |
Ejemplares similares
-
Commentary: Beyond “TRIM” Benefits of β-Glucan by Blood Glucose and Lipid Balancing Potentials in Its Defense Against COVID-19
por: Ikewaki, Nobunao, et al.
Publicado: (2021) -
β-glucans: wide-spectrum immune-balancing food-supplement-based enteric (β-WIFE) vaccine adjuvant approach to COVID-19
por: Ikewaki, Nobunao, et al.
Publicado: (2021) -
Coagulopathy associated with COVID-19 – Perspectives & Preventive strategies using a biological response modifier Glucan
por: Ikewaki, Nobunao, et al.
Publicado: (2020) -
Beneficial Immune Regulation by Biological Response Modifier Glucans in COVID-19 and Their Envisaged Potentials in the Management of Sepsis
por: Preethy, Senthilkumar, et al.
Publicado: (2022) -
Antibody dependent disease enhancement (ADE) after COVID-19 vaccination and beta glucans as a safer strategy in management
por: Ikewaki, Nobunao, et al.
Publicado: (2023)